Immunohistochemical Expression of NKX3.1 in Prostatic Adenocarcinoma Correlates with Tumors Grade among Sudanese

Background: The second most frequent cancer in males and the fourth most common cancer overall for both sexes is prostate cancer. On chromosome 8p, there is a prostatic tumor suppressor gene called NKX3.1. Despite the fact that the majority of primary prostatic adenocarcinomas exhibit positive NKX3.1 protein staining. Objective: The purpose of this study was to evaluate the immunohistochemical expression of NKX3.1in prostate adenocarcinoma and correlate it with tumor grades among Sudanese patients. Materials and Methods: This study is a retrospective descriptive cross- sectional study, was conducted in Khartoum state, (Radiation& Istopes Center- Khartoum (RICK)). Tissue sections were stained by immunohistochemical staining against NKX3.1 (indirect dextral polymers (Dako- EnVision TM Flex kit)) was carried out on forty (40) archival formalin fixed paraffin embedded tissue blocks from patients diagnosed as prostate carcinoma. Data were collected from hospital records and the immunohistochemical results and then analyzed using SPSS 25.0 frequency, and Chi-Square and mean were calculated. Results: The study found that the most frequent age group is between (71 – 80) years old, twenty (20) cases have prostate adenocarcinoma grade III, twelve (12) cases were grade II, and eight (8) cases were grade I. Any nuclear NKX3.1 staining was regarded as positive. Thirty-five (35%) have NKX3 positive immunostain while (65%) have a negative result. There is a statistically significant correlation between the NKX3.1 expressions and tumor grade as the P. value was (0.000), while in a statistically significant correlation between the NKX3 expressions and patients' age as the P. value was (0.957). Conclusions: NKX3 immuno expression is strongly associated with higher tumor grade and may prove the role of this protein in the progression of prostate cancer.

Authors

Publication Details

Journal
Archives of Clinical and Experimental Pathology
Published
2024-08-19
DOI
https://doi.org/10.31579/2834-8508/032
Primary Topic
Prostate Cancer Treatment and Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Immunohistochemical Expression of NKX3.1 in Prostatic Adenocarcinoma Correlates with Tumors Grade among Sudanese

Mosab Nouraldein Mohammed Hamad
Archives of Clinical and Experimental Pathology
Prostate Cancer Treatment and Research
article

Immunohistochemical Expression of NKX3.1 in Prostatic Adenocarcinoma Correlates with Tumors Grade among Sudanese

Mosab Nouraldein Mohammed Hamad
article en

Abstract

Background: The second most frequent cancer in males and the fourth most common cancer overall for both sexes is prostate cancer. On chromosome 8p, there is a prostatic tumor suppressor gene called NKX3.1. Despite the fact that the majority of primary prostatic adenocarcinomas exhibit positive NKX3.1 protein staining. Objective: The purpose of this study was to evaluate the immunohistochemical expression of NKX3.1in prostate adenocarcinoma and correlate it with tumor grades among Sudanese patients. Materials and Methods: This study is a retrospective descriptive cross- sectional study, was conducted in Khartoum state, (Radiation& Istopes Center- Khartoum (RICK)). Tissue sections were stained by immunohistochemical staining against NKX3.1 (indirect dextral polymers (Dako- EnVision TM Flex kit)) was carried out on forty (40) archival formalin fixed paraffin embedded tissue blocks from patients diagnosed as prostate carcinoma. Data were collected from hospital records and the immunohistochemical results and then analyzed using SPSS 25.0 frequency, and Chi-Square and mean were calculated. Results: The study found that the most frequent age group is between (71 – 80) years old, twenty (20) cases have prostate adenocarcinoma grade III, twelve (12) cases were grade II, and eight (8) cases were grade I. Any nuclear NKX3.1 staining was regarded as positive. Thirty-five (35%) have NKX3 positive immunostain while (65%) have a negative result. There is a statistically significant correlation between the NKX3.1 expressions and tumor grade as the P. value was (0.000), while in a statistically significant correlation between the NKX3 expressions and patients' age as the P. value was (0.957). Conclusions: NKX3 immuno expression is strongly associated with higher tumor grade and may prove the role of this protein in the progression of prostate cancer.

Archives of Clinical and Experimental PathologyVol. 3(4)
Openalex Percentile: Top 55%
Prostate Cancer Treatment and Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.